We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-14.64%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$683B
AUM Growth
-$118B
Cap. Flow
+$16.8B
Cap. Flow %
2.46%
Top 10 Hldgs %
22.55%
Holding
5,106
New
131
Increased
2,878
Reduced
1,465
Closed
89

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$956M
2
AAPL icon
Apple
AAPL
+$935M
3
WBD icon
Warner Bros
WBD
+$783M
4
HD icon
Home Depot
HD
+$626M
5
AMZN icon
Amazon
AMZN
+$476M

Sector Composition

Rank Sector Weight
1 Technology 23.95%
2 Healthcare 14.76%
3 Financials 13.17%
4 Consumer Discretionary 10.3%
5 Industrials 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRPX
4551
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$111K ﹤0.01%
265
+13
+5% +$5.33K
ENSC icon
4552
Ensysce Biosciences
ENSC
$6.46M
$110K ﹤0.01%
35
+4
+13% +$11.2K
FENC icon
4553
Fennec Pharmaceuticals
FENC
$448M
$110K ﹤0.01%
19,507
GILT icon
4554
Gilat Satellite Networks
GILT
$864M
$110K ﹤0.01%
18,319
JVA icon
4555
Coffee Holding Co
JVA
$19.9M
$110K ﹤0.01%
45,157
+735
+2% +$2.17K
SSAA
4556
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
$110K ﹤0.01%
11,309
EVFM
4557
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$110K ﹤0.01%
97,953
-3,471
-3% -$5.72K
PEI
4558
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$110K ﹤0.01%
33,133
-4
-0% -$26
AWRE icon
4559
Aware
AWRE
$26.8M
$108K ﹤0.01%
45,662
+970
+2% +$2.58K
MREO
4560
Mereo BioPharma
MREO
$48.8M
$108K ﹤0.01%
96,630
NOK icon
4561
Nokia
NOK
$52.7B
$108K ﹤0.01%
23,547
-5,993
-20% -$29.9K
SNOA icon
4562
Sonoma Pharmaceuticals
SNOA
$6.56M
$108K ﹤0.01%
1,844
SHPW
4563
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$108K ﹤0.01%
11,645
RBCN
4564
DELISTED
Rubicon Technology, Inc.
RBCN
$108K ﹤0.01%
11,843
+277
+2% +$2.53K
AILE
4565
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$108K ﹤0.01%
11,073
TCRX icon
4566
TScan Therapeutics
TCRX
$50.8M
$107K ﹤0.01%
34,101
+942
+3% +$2.58K
MOTS
4567
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$107K ﹤0.01%
1,268
+118
+10% +$9.86K
HCII
4568
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$107K ﹤0.01%
10,912
AONC
4569
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$106K ﹤0.01%
10,892
VAXX
4570
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$106K ﹤0.01%
68,096
ESSC
4571
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$106K ﹤0.01%
10,409
CRNT icon
4572
Ceragon Networks
CRNT
$199M
$105K ﹤0.01%
40,973
WEAV icon
4573
Weave Communications
WEAV
$402M
$105K ﹤0.01%
34,706
+8,303
+31% +$39.9K
SPRB
4574
Spruce Biosciences
SPRB
$128M
$105K ﹤0.01%
810
-884
-52% -$113K
MIST icon
4575
Milestone Pharmaceuticals
MIST
$158M
$104K ﹤0.01%
17,576

Similar funds

Geode Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 131 new positions and exited 89, leaving the 5,106-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
  • Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
  • Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
  • Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
  • Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
  • Geode Capital Management opened 131 new positions and closed 89 in Q2 2022.
  • Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.

Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.